• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

E2Z:GR

10.750 EUR 0.065 0.60%

As of 08:00:10 ET on 07/25/2014.

Snapshot for Almirall SA (E2Z)

Open: 10.719 Day's Range: 10.650 - 10.750 Volume: 750
Previous Close: 10.815 52wk Range: 8.560 - 13.000 1-Yr Rtn: +1.51%

Stock Chart for E2Z

No chart data available.
  • E2Z:GR 10.750
  • 1D
  • 1M
  • 1Y
10.815
Interactive E2Z Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for E2Z

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 27.0781
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.3970
Est. PEG Ratio 0.6793
Market Cap (M EUR) 1,859.22
Shares Outstanding (M) 172.95
30 Day Average Volume 388
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 05/19/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for E2Z

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for E2Z

Almirall SA is an international pharmaceutical company. The Company produces allergy and respiratory, cardiovascular, central nervous system, digestive, infectious disease, oncology, osteomuscular, pediatric, and urology drugs.

Jorge Gallardo BallartChairmanAntonio Gallardo BallartFirst Vice Chairman
Daniel Bravo AndreuSecond Vice ChairmanEduardo Javier Sanchiz YrazuChief Executive Officer
More Company Profile & Key Executives for E2Z

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil